Theralase Technologies Market Cap

Theralase Technologies has a market cap or net worth of CAD 82.15 million as of February 9, 2026. Its market cap has increased by 27.52% in one year.

Market Cap

82.15M

Enterprise Value

82.39M

Revenue

1.00M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.31

Market Cap Chart

Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 82.15M, an increase of 886.49%. That is a compound annual growth rate of 7.96%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	82.15M	87.95%
Dec 31, 2025	43.71M	-33.43%
Dec 31, 2024	65.66M	64.23%
Dec 28, 2023	39.98M	-42.29%
Dec 30, 2022	69.28M	-9.56%
Dec 31, 2021	76.60M	97.37%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Profound Medical	318.29M
Cannabix Technologies	70.22M
Conavi Medical	43.44M
Perimeter Medical Imaging AI	33.44M
Cheelcare	29.64M
Aurora Spine	23.24M
Ventripoint Diagnostics	22.73M
VVT Med	18.07M

Market Cap Rankings